정형외과수술 계획 소프트웨어 시장 규모 : 유형, 제공 형태, 용도, 최종 용도별, 세계 예측(2023-2032년)

Orthopedic Surgical Planning Software Market size is estimated to record 7.1% CAGR from 2023-2032 attributed to the ongoing advancements in medical imaging technologies. Rising innovations in imaging modalities, such as 3D CT scans, MRI, and digital radiography are enabling the development of sophisticated software solutions for precise surgical planning. These advancements allow orthopedic surgeons to conduct detailed preoperative assessments, visualize complex anatomical structures, and simulate surgical procedures.

To that end, several industry players are focusing on developing advanced imaging technologies with surgical planning software to improve the accuracy of orthopedic interventions leading to enhanced surgical outcomes and patient satisfaction, thereby propelling the market outlook. For instance, in February 2022, Formus Labs, the world's first automated 3D planner for joint replacement operations, funded USD 5 million for the launch of its orthopedic surgery planning system to give doctors unique visibility into the pre-op planning process.

The orthopedic surgical planning software industry is segmented into type, mode of delivery, application, end-use, and region.

Based on type, the post-operative orthopedic surgical planning software market is expected to gain significant traction between 2023 and 2032. The integration of data analytics and imaging technology is enhancing the accuracy of post-operative assessments for enabling healthcare providers to ensure optimal recovery and long-term patient well-being. Additionally, the increasing emphasis on personalized post-operative care will propel the segment growth.

The orthopedic oncology application segment accounted for sizable share of the orthopedic surgical planning software industry in 2022 and is estimated to depict robust growth through 2032 attributed to the increasing focus on personalized and comprehensive oncological care. Advanced software solutions are revolutionizing the treatment of orthopedic tumors while enabling precise preoperative planning and tailored surgical interventions. With the integration of advanced imaging and 3D modeling, these software applications are facilitating accurate tumor localization for aiding the precise resection of cancerous tissues while preserving healthy structures.

Regionally, the Asia Pacific orthopedic surgical planning software industry is set to grow at robust growth rate from 2023-2032 driven by the increasing healthcare infrastructure development and the rising geriatric population. The surging prevalence of orthopedic disorders and the growing demand for precise surgical interventions are fueling the adoption of advanced planning software solutions. Moreover, the growing focus on improving patient outcomes and the higher adoption of advanced healthcare technologies will augment the regional market outlook.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast parameters
• 1.4 COVID-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Global orthopedic surgical planning software industry 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Type trends
  • 2.1.4 Mode of delivery trends
  • 2.1.5 Application trends
  • 2.1.6 End-use trends

Chapter 3 Orthopedic Surgical Planning Software Industry Insights

• 3.1 Industry landscape
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing geriatric population and rising number of orthopedic procedures
    • 3.2.1.2 Growing preference for minimally invasive surgeries and personalized treatment strategies
    • 3.2.1.3 Technological advancements in imaging technology
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High costs associated with implementing and maintaining orthopedic surgical planning software
    • 3.2.2.2 Limited access to advanced technologies in certain regions
• 3.3 Growth potential analysis
  • 3.3.1 By type
  • 3.3.2 By mode of delivery
  • 3.3.3 By application
  • 3.3.4 Bt end-use
• 3.4 COVID- 19 impact analysis
• 3.5 Regulatory landscape
  • 3.5.1 U.S.
  • 3.5.2 Europe
• 3.6 Technology landscape
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive analysis of major market players
• 4.4 Company positioning matrix
• 4.5 Strategy dashboard, 2022

Chapter 5 Orthopedic Surgical Planning Software Market, By Type, 2018 - 2032 (USD Million)

• 5.1 Key trends, by type
• 5.2 Pre-operative
• 5.3 Post-operative

Chapter 6 Orthopedic Surgical Planning Software Market, By Mode of Delivery, 2018 - 2032 (USD Million)

• 6.1 Key trends, by mode of delivery
• 6.2 Cloud-based
• 6.3 On-premise

Chapter 7 Orthopedic Surgical Planning Software Market, By Application, 2018 - 2032 (USD Million)

• 7.1 Key trends, by application
• 7.2 Joint replacement
  • 7.2.1 Knee relacement
  • 7.2.2 Hip replacement
  • 7.2.3 Shoulder relacement
  • 7.2.4 Other joint replacements
• 7.3 Orthopedic oncology

Chapter 8 Orthopedic Surgical Planning Software Market, By End-use, 2018 - 2032 (USD Million)

• 8.1 Key trends, by end-use
• 8.2 Hospitals
• 8.3 Orthopedic Clinics
• 8.4 Ambulatory surgical centers

Chapter 9 Orthopedic Surgical Planning Software Market, By Region, 2018 - 2032 (USD Million)

• 9.1 Key trends, by region
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Rest of Latin America
• 9.6 MEA
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 Rest of MEA

Chapter 10 Company Profiles

• 10.1 EOS Imaging
• 10.2 Formus Labs Ltd
• 10.3 Stryker
• 10.4 Brainlab AG
• 10.5 mediCAD
• 10.6 PEEK HEALTH S.A.
• 10.7 Radlink Inc.
• 10.8 Zimmer Biomet
• 10.9 RSA Biomedical
• 10.10 Corin Group
• 10.11 Enhatch Inc.